Cargando…
KEAP1 Mutations Drive Tumorigenesis by Suppressing SOX9 Ubiquitination and Degradation
The transcription factor SOX9 is frequently amplified in diverse advanced‐stage human tumors. Its stability has been shown to be tightly controlled by ubiquitination‐dependent proteasome degradation. However, the exact underlying molecular mechanisms remain unclear. This work reports that SOX9 prote...
Autores principales: | Shao, Na, Huang, Hong, Idris, Muhammad, Peng, Xu, Xu, Feng, Dong, Shiwu, Liu, Chungang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610265/ https://www.ncbi.nlm.nih.gov/pubmed/33173725 http://dx.doi.org/10.1002/advs.202001018 |
Ejemplares similares
-
Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53
por: Chen, Yajie, et al.
Publicado: (2019) -
ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer
por: Purohit, Vinee, et al.
Publicado: (2021) -
IL-13/IL-13RA2 signaling promotes colorectal cancer stem cell tumorigenesis by inducing ubiquitinated degradation of p53
por: He, Baoyu, et al.
Publicado: (2023) -
Loss-of-function mutations in KEAP1 drive lung cancer progression via KEAP1/NRF2 pathway activation
por: Gong, Meiling, et al.
Publicado: (2020) -
GASC1 promotes hepatocellular carcinoma progression by inhibiting the degradation of ROCK2
por: Shao, Na, et al.
Publicado: (2021)